GxPinnacle Logo
Skip to content

What Do Inspectors Check for Delegation, Backup and Escalation Authority in Pharmacovigilance?

Pharmacovigilance systems must define delegation, backup coverage, and escalation authority. Regulators expect clear responsibility transfer, continuous availability, and defined decision-making authority across all PV activities.

For: Founders, CEOs & MDs·PV Leads·QA/Compliance·Scientists tasked with documentation

Alignment: Global pharmacovigilance principles (ICH-aligned) and inspection practices

Most useful when: Preparing for inspection, setting up a process, or closing a documentation gap

Key points

  • Pharmacovigilance systems must define clear delegation and backup arrangements for all roles.
  • Responsibilities must be transferable without loss of control or compliance.
  • Escalation pathways must be defined for safety issues and decision-making.
  • Authority levels must be documented for each role and escalation tier.
  • Backup coverage must ensure continuous availability of PV oversight.
  • Inspection-ready evidence must demonstrate that delegation, escalation, and continuity are controlled and effective.

What inspectors expect

Each point below should be supported by controlled documents and traceable records.

  • Delegation must not result in loss of control or accountability.
  • Backup arrangements must ensure continuous PV system operation.
  • Escalation pathways must be clearly defined and followed.
  • Authority for decision-making must be documented.
  • Responsibility must remain clear even during delegation or absence.

Summary

Inspectors assess whether pharmacovigilance systems maintain control through delegation, backup, and escalation processes. They review how responsibilities are transferred, how decisions are escalated, and how continuity of PV activities is maintained under all circumstances.

Common questions

These are the questions this page is designed to answer directly.

  • How is delegation managed in pharmacovigilance?
  • What do inspectors check for PV escalation processes?
  • How do you ensure backup coverage in pharmacovigilance?
  • Who can make decisions in pharmacovigilance systems?
  • What is escalation authority in PV?
  • How are responsibilities transferred in pharmacovigilance?
  • What happens if a PV role is unavailable?
  • How do regulators assess PV escalation processes?
  • What is backup coverage in pharmacovigilance?
  • How do you maintain continuity in PV systems?

Evidence objects inspectors expect

Delegation Records and Logs

  • Formal delegation records for PV responsibilities
  • Temporary role assignment documentation
  • Defined delegation scope and limitations
  • Approval of delegated responsibilities

Backup and Coverage Arrangements

  • Deputy QPPV designation
  • Backup roles for critical PV functions
  • 24/7 availability coverage plans
  • Handover documentation during absence

Escalation Procedures

  • Defined escalation pathways for safety issues
  • Escalation timelines for urgent cases
  • Decision-making hierarchy documentation
  • Communication protocols for escalation

Authority and Decision-Making Framework

  • Defined authority levels for each role
  • Decision-making rights for safety-critical issues
  • Authority to escalate or override decisions
  • Governance approval structures

Continuity and System Control Evidence

  • Evidence of continuous PV system oversight
  • Documentation showing no gaps during absence
  • Case examples of delegation or escalation
  • Governance records supporting decision-making

Regulatory Basis (Primary Sources)

  • GVP Module I – requirement for continuous PV system control and defined responsibilities
  • GVP Module VI – requirements for safety data management and escalation
  • ICH E2D – expectations for maintaining continuous safety system operation
  • MHRA GPvP guidance – requirements for availability and oversight of PV roles
  • FDA pharmacovigilance guidance – accountability and continuity of safety oversight

Typical Inspection Questions (What Inspectors Ask)

  • What happens if your QPPV is unavailable?
  • How do you ensure continuous PV oversight?
  • Who can make safety decisions in urgent situations?
  • How are responsibilities delegated and documented?
  • Show me how escalation is handled in your system.

Failure patterns

Delegation occurs without clear documentation or control.

No defined backup for critical PV roles.

Escalation pathways are unclear or not followed.

Authority for decision-making is not defined.

Gaps occur in PV oversight during absence or transition.

What good looks like

  • Clear delegation records and defined responsibility transfer.
  • Effective backup and coverage for all critical PV roles.
  • Defined escalation pathways for safety issues.
  • Documented authority and decision-making framework.
  • Continuous control and oversight of the PV system.

Operationalisation

  • Define delegation processes within PV SOPs.
  • Assign deputies and backup roles for critical positions.
  • Establish escalation pathways and decision-making hierarchy.
  • Document authority levels for all PV roles.
  • Ensure continuity of PV operations during absence or change.
  • Maintain records demonstrating delegation and escalation in practice.

Need regulatory documentation today?

Save time and reduce inspection risk with structured, pre-built process-ready documentation.
Created by industry professionals, adaptable to your organisation.

Related pre-built documentation inside the app

Get AccessLog In

FAQ

What is delegation in pharmacovigilance?

Delegation is the temporary or permanent transfer of responsibilities to another qualified individual while maintaining overall accountability.

Who is responsible when pharmacovigilance tasks are delegated?

Responsibility remains with the Marketing Authorisation Holder and relevant oversight roles such as the QPPV, even when tasks are delegated. Delegation does not transfer accountability, and the organisation must maintain control and oversight of all delegated activities.

How is backup coverage managed in pharmacovigilance?

Backup coverage is managed through defined deputy roles, handover procedures, and continuous availability arrangements.

What is escalation authority in pharmacovigilance?

Escalation authority defines who can make decisions and take action when safety issues arise.

Do inspectors review delegation and escalation processes?

Yes. Inspectors assess whether responsibilities are clearly defined, delegated appropriately, and supported by escalation pathways.

What happens if there is no backup coverage in PV?

Lack of backup coverage can result in inspection findings due to gaps in oversight and system control.

How do you ensure continuous PV system operation?

Continuous operation is ensured through delegation, backup coverage, defined escalation pathways, and governance oversight.

Sources

Primary guidance used to inform this map. This page is a structured interpretation layer; always validate against the original source documents.

European Medicines Agency (EMA)

  • Guideline on good pharmacovigilance practices (GVP) – Module I
    View source
  • Guideline on good pharmacovigilance practices (GVP) – Module VI
    View source

FDA

ICH

MHRA